Share: Facebook Twitter LinkedIn
Activity Provided By:

Evolve Medical Education LLC

New Pharmacotherapeutics for the Treatment of Glaucoma: Targeting the Trabecular Meshwork

Access Activity

Overview / Abstract:

CONTENT SOURCE
This continuing medical education (CME)/continuing education (CE) activity captures content from a roundtable discussion.

ACTIVITY DESCRIPTION
The development and commercialization of two new topical glaucoma drugs has renewed interest in medical therapy. In late 2017, after a 2-decade gap in glaucoma pharmacology innovation, two drugs in novel classes were approved for IOP reduction in eyes with ocular hypertension or open-angle glaucoma. These drugs lower IOP through unique mechanisms of action not previously available with existing drug choices. This activity will provide education on the efficacy, safety, and mechanism of action of these two new drugs.

Expiration

Dec 22, 2022

Discipline(s)

Optometry / Ophthalmology CE

Format

Journal

Credits / Hours

1

Accreditation

ACCME, COPE/ARBO

Presenters / Authors / Faculty

Thomas W. Samuelson, MD; Jason Bacharach, MD; Murray Fingeret, OD, FAAO; Albert S. Khouri, MD; and Constance Okeke, MD, MSCE

Sponsors / Supporters / Grant Providers

Supported by unrestricted educational grants from Aerie and Bausch + Lomb.

Keywords / Search Terms

Evolve Medical Education LLC Glaucoma, IOP, ophthalmology, optometry, topical medications Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map